Mkts

Oncolytics Biotech Inc.

NASDAQ: ONCY
$0.44+0.00 (-1.04%)
As of Oct 29, 9:31 AM ET

Key statistics

Day range
0.440.45
52-week range
1.484.49
Today
Open0.45
Previous close0.44
Volume—
Valuation
Market cap94.18M
P/E ratio—
EPS (TTM)-0.37
Income & risk
Dividend / yield—
Beta0.84
Avg volume2.04M
Discussion

ONCY News

Stories mentioning ONCY from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q1 '25Mar 31
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.00
Operating Expenses
Research & Development4,5522,800
Sales General & Admin
Total Operating Expenses9,2815,021
Operating Income (Loss)(9,281)(5,021)
Interest Income44.00117.00
Interest Expense
Other Expense38.00310.00
Pretax Income
Tax Provision
Net Income (Loss)(9,243)(4,711)
Earnings Per Share (Basic)(0.08)(0.06)
Earnings Per Share (Diluted)(0.08)(0.06)
Weighted Average Shares Outstanding (Basic)112,29384,631
Weighted Average Shares Outstanding (Diluted)112,29384,631

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ONCY

Oncolytics Biotech Inc. (NASDAQ: ONCY) is a stock listed on the Nasdaq Stock Market under the ticker symbol ONCY. It last traded at $0.4400 (Oct 29, 2026, 9:31 AM ET), down 1.0% on the day. That gives Oncolytics Biotech a market capitalisation of $94.2M.

Over the past 52 weeks ONCY has traded between $1.48 and $4.49.

For the quarter ended Mar 31, 2026 it reported a net loss of $9.2M.

Last 2 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$9.2M
Mar 31, 2025—-$4.7M

From Oncolytics Biotech’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…